Literature DB >> 23815585

1,3,4-oxadiazole derivatives as potential biological agents.

Juan Sun1, Jigar A Makawana, Hai-Liang Zhu.   

Abstract

The synthesis of novel compound libraries along with screening is a rapid and effective approach for the discovery of potential chemical agents, and it becomes an important method in pharmaceutical chemistry research. 1,3,4- oxadiazole derivatives as the typical heterocyclic compounds, exhibit a broad spectrum of biological activities and vital leading compounds for the development of chemical drugs. Herein, we focus on the synthesis and screening of novel 1,3,4-oxadiazoles derivatives with antimicrobial, antitumor or antiviral activities during the past decade. In this review, we discussed the synthetic development of 1,3,4-oxadiazoles derivatives, and also the relevant bioactivity and their prospects as the potential chemical drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815585     DOI: 10.2174/13895575113139990071

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  7 in total

1.  1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities.

Authors:  Marwa Ali A Fathi; Amer Ali Abd El-Hafeez; Dalia Abdelhamid; Samar H Abbas; Monica M Montano; Mohamed Abdel-Aziz
Journal:  Bioorg Chem       Date:  2018-11-22       Impact factor: 5.275

2.  Synthesis of a series of novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as potential antioxidant and antibacterial agents.

Authors:  M Aruna Sindhe; Yadav D Bodke; R Kenchappa; Sandeep Telkar; A Chandrashekar
Journal:  J Chem Biol       Date:  2016-07-07

3.  Synthesis of Some Benzimidazole Derivatives Bearing 1,3,4-Oxadiazole Moiety as Anticancer Agents.

Authors:  Bereket Mochona; Elizabeth Mazzio; Madhavei Gangapurum; Nelly Mateeva; K K Redda
Journal:  Chem Sci Trans       Date:  2015-04

4.  Synthesis and Cytotoxic Evaluation of Pyrrole Hetarylazoles Containing Benzimidazole/Pyrazolone/1,3,4-Oxadiazole Motifs.

Authors:  Bereket Mochona; Timothy Jackson; DeCoria McCauley; Elizabeth Mazzio; Kinfe K Redda
Journal:  J Heterocycl Chem       Date:  2015-09-18       Impact factor: 2.193

5.  Crystal structure of 2-(4-fluoro-3-methyl-phen-yl)-5-{[(naphthalen-1-yl)-oxy]meth-yl}-1,3,4-oxa-diazole.

Authors:  Muniyappan Govindhan; Kathavarayan Subramanian; Vijayan Viswanathan; Devadasan Velmurugan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-03-11

6.  The cyanobacterial metabolite nocuolin a is a natural oxadiazine that triggers apoptosis in human cancer cells.

Authors:  Kateřina Voráčová; Jan Hájek; Jan Mareš; Petra Urajová; Marek Kuzma; José Cheel; Andreas Villunger; Alexandra Kapuscik; Marcel Bally; Petr Novák; Martin Kabeláč; Gerhard Krumschnabel; Martin Lukeš; Ludmila Voloshko; Jiří Kopecký; Pavel Hrouzek
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

7.  Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives.

Authors:  Az-Eddine El Mansouri; Saida Lachhab; Ali Oubella; Mehdi Ahmad; Johan Neyts; Dirk Jochmans; Winston Chiu; Laura Vangeel; Steven De Jonghe; Hamid Morjani; Mustapha Ait Ali; Mohamed Zahouily; Yogesh S Sanghvi; Hassan B Lazrek
Journal:  J Mol Struct       Date:  2022-09-09       Impact factor: 3.841

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.